Skip to main content
Home
    • ALL Specialities ALL Specialities
    Home
    Home

    Mark Lesney, PhD

    News

    CD123 may be a marker for residual disease and response evaluation in AML and B-ALL

    Author:
    Mark Lesney, PhD
    Publish date: May 15, 2020

    CD123 expression appears positively correlated with the presence of minimal residual disease (MRD) after...

    • Read More

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties